6c7e

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6c7e is ON HOLD until Paper Publication
+
==Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide==
 +
<StructureSection load='6c7e' size='340' side='right' caption='[[6c7e]], [[Resolution|resolution]] 1.43&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[6c7e]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6C7E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6C7E FirstGlance]. <br>
 +
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EOG:1-(2-chlorophenyl)-N,4-dimethyl[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide'>EOG</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
 +
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/3',5'-cyclic-nucleotide_phosphodiesterase 3',5'-cyclic-nucleotide phosphodiesterase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.4.17 3.1.4.17] </span></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6c7e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6c7e OCA], [http://pdbe.org/6c7e PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6c7e RCSB], [http://www.ebi.ac.uk/pdbsum/6c7e PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6c7e ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/PDE2A_HUMAN PDE2A_HUMAN]] Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.<ref>PMID:15938621</ref> <ref>PMID:19828435</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
In medicinal chemistry, additivity-based SAR analysis rests on three assumptions: (1) con-sistent binding pose of the central scaffold, (2) no interaction between the substitutions, and (3) a relatively rigid binding pocket in which the two substitutions act independently. Previously, non-additive SAR have been documented in systems that deviate from the first two assump-tions. Interestingly, protein structural change upon ligand binding, through induced fit or con-formational selection, although a well-known phenomenon that invalidates the third assump-tion, has not been linked to non-additive SAR conclusively. Here, for the first time, we show clear structural evidence that the formation of a hydrophobic pocket upon ligand binding in PDE2 catalytic site reduces the size of another distinct sub-pocket, and contribute to strong non-additive SAR between two otherwise distant R groups.
-
Authors:
+
Mathematical and Structural Characterization of Strong Non-additive SAR Caused by Protein Conformational Changes.,Gomez L, Xu R, Sinko W, Selfridge B, Vernier WF, Ly K, Truong R, Metz M, Marrone T, Sebring K, Yan Y, Appleton B, Aertgeerts K, Massari E, Breitenbucher JG J Med Chem. 2018 Aug 2. doi: 10.1021/acs.jmedchem.8b00713. PMID:30070482<ref>PMID:30070482</ref>
-
Description:
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
 +
<div class="pdbe-citations 6c7e" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]]
 +
[[Category: Aertgeerts, K]]
 +
[[Category: Xu, R]]
 +
[[Category: Hydrolase]]
 +
[[Category: Phosphodiesterase]]

Revision as of 16:12, 15 August 2018

Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide

6c7e, resolution 1.43Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools